FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears Siemens NAEOTOM Alpha CT Device

FDA clears the Siemens Medical Solutions NAEOTOM Alpha improved CT imaging device, described by the agency as the first major CT technology change in ...

Human Drugs

CDER Drug Safety Staff Changes

CDER drug safety operations (DSO) associate director Terry Toigo retires and, in the interim, DSO senior staff member Amy Ramanadham has been named ac...

Human Drugs

Appeals Court Reverses Catalyst Firdapse Loss to FDA

The 11th Circuit Court of Appeals tells a Florida federal court it erred in granting summary judgment to FDA and Jacobus over orphan drug exclusivity ...

Human Drugs

Bipartisan Drug Supply Chain Bill Introduced

Bills in the House and Senate would create an emergency supply of active pharmaceutical ingredients needed to make essential generic drugs.

Human Drugs

Apellis Plans NDA for Blindness Drug

Apellis Pharmaceuticals says it will file an NDA for pegcetacoplan, an investigational, targeted C3 therapy treating geographic atrophy secondary to a...

Human Drugs

Ex-CDER Official Laughren Retained by PharmaTher

PharmaTher Holdings retains former CDER antipsychotic guru Thomas Laughren as a regulatory affairs advisor to help a depression therapy.

Human Drugs

FDA Approves AbbVies Qulipta for Migraine Prevention

FDA approves AbbVies novel migraine prevention drug Qulipta.

Safety Reporting Investigator Responsibility Guidance

FDA publishes a draft guidance on investigator responsibilities for safety reporting for INDs and IDEs.

Human Drugs

Guidance on Microbiological Quality in Non-Sterile Drugs

FDA publishes a draft guidance on microbiological quality control of non-sterile drugs.

Federal Register

Tropical Disease Review Voucher Fee Rate

Federal Register notice: FDA announces the fee rates for using a tropical disease priority review voucher for fiscal year 2022 $1,266,651.